Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-09

FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Zidovudine filed by Aurobindo Pharma Limited, enabling continued marketing of the generic drug Zidovudine under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zidovudine (Zidovudine)

Snippet

SUPPL AP for ZIDOVUDINE (ZIDOVUDINE)